Lv1
38 积分 2024-10-03 加入
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
1天前
已完结
Machine learning-based pathomics model predicts ANGPT2 expression and prognosis in hepatocellular carcinoma
1个月前
已完结
Evaluation of hyperprogressive disease with atezolizumab plus bevacizumab for hepatocellular carcinoma: A secondary analysis of the IMbrave150 trial
1个月前
已完结
The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy
1个月前
已完结
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma
6个月前
已完结
Potential involvement of oncostatin M in the immunosuppressive tumor immune microenvironment in hepatocellular carcinoma with vessels encapsulating tumor clusters
7个月前
已完结
Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma
7个月前
已完结
Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma
7个月前
已完结
PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration
7个月前
已完结
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
7个月前
已完结
皖公网安备34019202002308
